// App-Quantinova.ai

P989 : Questioning the Janus Kinase (JAK) Inhibitors!

Researchers

Presenter

  • H. Hussain

Principal Investigators

  • S. Faryad

  • D. Taneja

Medical Centers

  • Pulmonary and Critical Care Medicine, University of Illinois College of Medicine at Peoria, Peoria, IL, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

Disease

  • Deep vein thrombosis

  • Dyspnea

  • Venous thrombosis

  • Seizures sensorineural deafness ataxia mental retardation electrolyte imbalance

Biomarkers

  • D-dimer

  • Janus kinase

Drug/Treatment

  • ABT-494

  • Baricitinib

  • Tasocitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved